Forte Biosciences Inc (FBRX)
Forte Biosciences Inc (FBRX) is a NASDAQ-listed biotechnology company. Forte Biosciences Inc common stock is the security described here, and the supplied security context is common equity, indicating an ownership interest in the company rather than a fund, note, or depositary receipt. The company is associated with research and development activity in the healthcare sector, with a focus on biotechnology and work related to immune-mediated conditions. This overview describes the listed shares only and does not imply investment characteristics or operating results. Investors typically use this kind of listing information to identify the issuer, exchange, sector, and instrument type.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Next Earnings Date | Price-to-Book Ratio | Market Cap | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-FBRX
|
Not available
|
Not available
|
Not available
|
Fair
|
November 16, 2026
|
10.6x
|
1.939 B
|
0.0%
|
74.1%
|
50.7
|
81.9%
|
